SNS-301
SNS-301-2-1
Phase 2 small_molecule terminated
Quick answer
SNS-301 for Myelodysplastic Syndromes is a Phase 2 program (small_molecule) at Sensei Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sensei Biotherapeutics
- Indication
- Myelodysplastic Syndromes
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated